Evaluation of the ICLEAR-EU intervention to integrate palliative care in the treatment of people with advanced COPD and their family caregivers: An international stepped wedge cluster RCT in six European countries. Chronic Obstructive Pulmonary Disease (COPD) is a devastating life-limiting lung disease with a high personal and societal burden. The symptom burden of people with COPD is as severe and burdensome as the symptom burden of people with lung COPD. While palliative care in many countries is available for people with lung COPD, palliative care and good end-of-life care for people with COPD are not well integrated into their treatment by respiratory hospital teams in Europe. The EU PAL-COPD project is a multidisciplinary, interprofessional, international and intersectoral project aiming at evaluating the clinical and cost-effectiveness of the ICLEAR-EU intervention for people with advanced COPD in different healthcare systems in Europe. ICLEAR-EU is a person-centred and family-centred non-pharmacological service intervention in which respiratory teams in the hospital collaborate with interdisciplinary palliative care teams and with primary care to promote shared decision-making and advance care planning, improve symptom treatment and comfort care, and prevent re-hospitalization after an exacerbation. ICLEAR-EU is based on an existing intervention developed and pilot tested in the UK. In EU PAL-COPD, the effectiveness of ICLEAR-EU will be assessed with a stepped wedge cluster RCT in 1,224 people with advanced COPD in 18 hospitals across six European countries. It is hence the first large-scale international trial on systematic integration of palliative care in respiratory care for people with advanced COPD. Cost-effectiveness, robust mixed methods subgroup analyses and in-depth process and implementation evaluations are also included
In plain English
AI plain-English summaryA hospital team in the UK has already shown that a structured palliative care plan helps people with advanced COPD avoid unwanted hospital admissions and die at home—now researchers are testing whether the same approach works across six European countries. The problem is that while lung cancer patients routinely receive palliative care integrated into their treatment, people with advanced COPD often do not. Their symptom burden is as severe as that of lung cancer patients, yet respiratory hospital teams in Europe rarely coordinate with palliative care or primary care to plan for end-of-life needs. This leaves patients and families without shared decision-making, advance care planning, or symptom management tailored to their worsening condition. If the ICLEAR-EU intervention proves effective, it could change how respiratory teams in hospitals across Europe routinely work. Instead of treating exacerbations in isolation, they would collaborate with palliative care specialists and primary care providers to identify unmet needs, discuss goals of care, and create a shared action plan. The result could be fewer unwanted hospital readmissions, more patients able to die at home, and a care pathway that treats advanced COPD as a life-limiting illness requiring coordinated, person-centred support—not just acute medical management.
View original technical description
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Respiratory MedicinePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know